Balyasny Asset Management’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.41M | Buy |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $892K | Buy |
|
|||||
|
2024
Q4 | $427K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $1.45M | Sell |
|
|||||
|
2023
Q4 | $7.97M | Buy |
|
|||||
|
2023
Q3 | $2.04M | Sell |
|
|||||
|
2023
Q2 | $7.8M | Sell |
|
|||||
|
2023
Q1 | $14.4M | Buy |
|
|||||
|
2022
Q4 | $1.99M | Sell |
|
|||||
|
2022
Q3 | $6.42M | Buy |
|
|||||
|
2022
Q2 | $5.02M | Sell |
|
|||||
|
2022
Q1 | $6.72M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $2.27M | Hold |
|
|||||
|
2017
Q3 | $3.13M | Hold |
|
|||||
|
2017
Q2 | $3.06M | Buy |
|
|||||
|
2017
Q1 | $2.2M | Buy |
|